Searched for
INJECTABLE MANUFACTURING EXPANSION
At Musk's Starbase, the rise of SpaceX brings fortunes and fracturesIn Texas, SpaceX's bustling Starbase is a double-edged sword, fueling economic growth while drawing thrill-seekers to the area. Unfortunate...
At Elon Musk's Starbase, the rise of SpaceX brings fortunes and fracturesSpaceX's rapid expansion in South Texas, centred around its Starbase facility, is bringing economic benefits and global attention. However,...
Policybazaar founder warns of insurance squeeze; IT's buying spreeHappy Wednesday! Policybazaar’s Yashish Dahiya has warned that proposed commission caps could disrupt the insurance distribution industry. ...
Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookGland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...
ET Prime Special Series: Multibagger or IBC - Part 57: Forging firm that supplies Tata, M&M, JCB. Nobody talks about it enoughFor over four decades, one company has been making crankshafts quietly and precisely, supplying customers from Tata Motors to Liebherr to M...
Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...
ET Prime Special Series: Multibagger or Bankrupt - Part 56: An acquisition, a divestment, and a JV for EV. Ready for re-rating?Bulls argue this company is becoming a complete mobility-platform supplier in India: Power solutions and aftermarket, braking and safety. B...
Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
Intel stock surge 28% to record high: how did a $8.9 billion Trump Intel stake become $28 billion, and what is Intel doing to dominate the AI boom?Intel stock surge just hit a historic peak. Shares of Intel jumped nearly 28% in one session. A $8.9 billion U.S. stake in Intel is now wor...
Nekkar Power secures ₹75 crore from Syndicate Finance for hydrogen fuel cell developmentSyndicate Finance has led a ₹75 crore second-round funding in Nekkar Power Pvt Ltd, a Hyderabad-based startup focused on hydrogen fuel cell...
Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...
Biological E to invest Rs 1800 crore to augment vaccine capacity, injectables, R&DAccording to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...
US-based Amneal Pharmaceuticals buys India's injectable maker Punishka Healthcare for Rs 700 croresAmneal Pharmaceuticals on Tuesday said it has acquired Ahmedabad-based injectable drug maker Puniska Healthcare Pvt. Ltd for a total value ...
Biological E acquires Akorn India to ramp up vaccine & injectable medicine capacitiesAkorn India, a subsidiary of the US-based Akorn Inc., has a manufacturing plant of 39,000 square metres over a 14-acre campus in Himachal P...
Milacron LLC to invest $30 million in India operationsMilacron LLC plans to further invest $20 million in its India operations at its Ahmedabad based facility.
- Pharma cos inject capacities to meet growing demand
Indian pharmaceutical companies with a presence in sterile injectables space are expanding capacities to cater to growing demand in this se...
- Strides Acrolab receives US FDA approval
The Rs 1000 crore generic pharma company has received US FDA inspection approval status for its steriles injectable complex at Bangalore.
- Texmo Pipes files DRHP with SEBI for IPO
Texmo Pipes and Products Limited, manufacturer of PVC and HDPE pipes, has filed its draft red herring prospectus with the SEBI for an IPO.
- Texmo Pipes files DRHP with SEBI for IPO
Texmo Pipes and Products Limited, manufacturer of PVC and HDPE pipes, has filed its draft red herring prospectus with the SEBI for an IPO.